NDCs not required under HHS rule
Neither national drug codes nor the Healthcare Common Procedure Coding System would be required as the standard for reporting drugs and biologics for non-retail pharmacy transactions under HHS proposed rule. NDCs will remain the standard for retail pharmacy. The Pharmaceutical Research & Manufacturers of America wants NDCs to be used as the basis for Medicare reimbursement (1"The Pink Sheet" April 22, p. 36)...
You may also be interested in...
The Centers for Medicare & Medicaid Services should eliminate the six-month marketing prerequisite for applying to receive an HCPCS code for Medicare reimbursement, PhRMA said in comments to HHS' Committee on Regulatory Reform
In the month ahead, a key ANDA approval could come for Viatris, while additional competition to Gilead Sciences’ Truvada for PrEP is on the way in the US following Teva and Amneal’s launches.
Sensyne obtained UK regulatory approval for its SYNE-COV machine learning algorithm to assess the long-term risks of COVID-19.